Article Data

  • Views 123
  • Dowloads 2

Review

Open Access

Anesthetics and cardioprotection

  • ZELJKO J. BOSNJAK1

1Departments of Anesthesiology and Physiology Medical College of Wisconsin

DOI: 10.22514/SV21.052007.1 Vol.2,Issue S1,May 2007 pp.6-10

Published: 01 May 2007

*Corresponding Author(s): ZELJKO J. BOSNJAK E-mail: mziebell@mcw.edu

PDF (57.32 kB)

Abstract

The prevalence of the cardiovascular disease significantly affects the outcome of both cardiac and non-cardiac surgery, and perioperative cardiac morbidity is one of the leading causes of death following anesthesia and surgery. The considerable incidence of myocardial infarction, congestive heart failure, myocardial ischemia, or serious dysrhythmias during the intraoperative or postoperative periods, has led many studies to examine medical factors and interventions for decreasing cardiac risk in patients with cardiovascular disease. An extensive amount of work has focused on whether any one anesthetic agent or technique is particularly beneficial for patients with coronary artery disease. Experimental studies conducted in our laboratory have clearly shown that volatile anesthetics may exert profound cardioprotection against myocardial ischemia and reperfusion injury. This article examines the recent evidence about the importance of mitochondria, reactive oxygen 

species and the KATP channels in cardioprotective signaling by volatile anesthetics. Moreover, the article addresses current concepts and controversies regarding specific roles of the mitochondrial and the sarcolemmal KATP channels in anesthetic-induced preconditioning.

Key words

preconditioning, volatile anesthetics, heart, coronary disease, ischemia, myocardial infarction, mitochondria

Cite And Share

ZELJKO J. BOSNJAK. Anesthetics and cardioprotection. Signa Vitae. 2007. 2(S1);6-10.

References

1. Murry CE, Jennings RB, Reimer KA: Peconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36

2. Deutsch E, Berger M, Kussmaul WG, Hirshfeld Jr. JW, Herrmann HC, Laskey WK: Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic features. Circulation 1990; 82: 2044-2051

3. De Hert SG TF, Mather S, Stowe DF: Cardioprotection with volatile anesthetics: mechanisms and clinical applications. Anesth Analg 2004; 100: 1584-1593

4. Zaugg M, Lucchinetti E, Garcia C, Pasch T, Spahn DR, Schaub MC: Anaesthetics and cardiac preconditioning. Part II. Clinical implications. British Journal of Anaesthesia 2003; 91: 566-76

5. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC: Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. British Journal of Anaesthesia 2003; 91: 551-65

6. Kwok W: The yin and yang of volatile anesthetic action on cardiac potassium channels. International Congress Series 2005; 1283: 96-101

7. Kwok WM AK: Preconditioning of the myocardium by volatile anesthetics. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 249-255

8. Pratt PF, Jr., Wang C, Weihrauch D, Bienengraeber MW, Kersten JR, Pagel PS, Warltier DC: Cardioprotection by volatile anesthetics: new applications for old drugs? Curr Opin Anaesthesiol 2006; 19: 397-403

9. Riess ML SD, Warltier DC: Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart & Circ Physiol 2004; 286: H1603-1607

10. Stowe DF, Kevin LG: Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal 2004; 6: 439-48

11. Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Cardioprotection by volatile anesthetics. Vascular Pharmacology 2005; 42: 243-52

12. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004; 100: 707-21

13. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100: II340-4

14. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE: Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004; 101: 9-20

15. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE: Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299-310

16. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003; 98: 1315-27

17. Tomai F, Crea F, Ghini AS, Proietti I, Gaspardone A, Versaci F, De Paulis R, Chiariello L, Gioffre PA: Ischemic preconditioning during coronary angioplasty is preserved in elderly patients [In Process Citation]. Ital Heart J 2000; 1: 562-8

18. Bosnjak ZJ, Warltier DC: New aspects of cardiac electrophysiology and function: Effects of inhalational anaesthetics. In:, Vol. 7, 1993 pp 

937- 960. Inhalation Anaesthesia. Bailliere Tindall Ltd, London 1993; 7: 937-60

19. Buljubasic N, Stowe DF, Marijic J, Roerig DL, Kampine JP, Bosnjak ZJ: Halothane reduces release of adenosine, inosine, and lactate with ischemia and reperfusion in isolated hearts. Anesth Analg 1993; 76: 54-62

20. An J, Stadnicka A, Kwok WM, Bosnjak ZJ: Contribution of reactive oxygen species to isoflurane-induced sensitization of cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil. Anesthesiology 2004; 100: 575-80

21. Chiari PC, Bienengraeber MW, Weihrauch D, Krolikowski JG, Kersten JR, Warltier DC, Pagel PS: Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology 2005; 103: 74-83

22. Fujimoto K, Bosnjak ZJ, Kwok WM: Isoflurane-induced facilitation of the cardiac sarcolemmal K(ATP) channel. Anesthesiology 2002; 97:

57- 65

23. Gassmayr S, Stadnicka A, Suzuki A, Kwok WM, Bosnjak ZJ: Isoflurane sensitizes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil. Anesthesiology 2003; 98: 114-20

24. Jamnicki-Abegg M, Weihrauch D, Pagel PS, Kersten JR, Bosnjak ZJ, Warltier DC, Bienengraeber MW: Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 2005; 103: 1006-14

25. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002; 96: 183-8

26. Kersten JR, Schmeling TJ, Hettrick DR, Pagel PS, Gross GA, Warltier DC: Mechanism of myocardial protection by isoflurane. Anesthesiology 1996; 85: 794-807

27. Kersten JR, Lowe D, Hettrick DA, Pagel PS, Gross GJ, Warltier DC: Glyburide, a KATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83: 27-33

28. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of KATP channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87: 361-370

29. Kohro S, Hogan QH, Nakae Y, Yamakage M, Bosnjak ZJ: Repeated or prolonged isoflurane exposure reduces mitochondrial oxidizing effects. Anesthesiology 2003; 98: 275-8

30. Kohro S, Hogan QH, Warltier DC, Bosnjak ZJ: Protein kinase C inhibitors produce mitochondrial flavoprotein oxidation in cardiac myocytes. Anesthesia & Analgesia 2004; 99: 1316-22

31. Krolikowski JG, Weihrauch D, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS: Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Canadian Journal of Anaesthesia 2006; 53: 174-82

32. Kwok WM, Martinelli AT, Fujimoto K, Suzuki A, Stadnicka A, Bosnjak ZJ: Differential modulation of the cardiac adenosine triphosphate-sensitive potassium channel by isoflurane and halothane. Anesthesiology 2002; 97: 50-6

33. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 2004; 100: 532-9

34. Nakae Y, Kohro S, Hogan QH, Bosnjak ZJ: Intracellular mechanism of mitochondrial adenosine triphosphate-sensitive potassium channel activation with isoflurane. Anesthesia & Analgesia 2003; 97: 1025-32

35. Nakae Y, Kwok WM, Bosnjak ZJ, Jiang MT: Isoflurane activates rat mitochondrial ATP-sensitive K+ channels reconstituted in lipid bilayers. American Journal of Physiology Heart & Circulatory Physiology 2003; 284

36. Novalija E, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, Stowe DF: Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology 2003; 99: 421-8

37. Pagel PS, Warltier DC, Kersten JR: Effectiveness of Isoflurane in Inducing Delayed Preconditioning against Myocardial Infarction In Vivo. Anesthesiology 2006; 104: 384-5

38. Riess ML, Stowe DF, Warltier DC: Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? American Journal of Physiology Heart & Circulatory Physiology 2004; 286

39. Schlack W, Preckel B, Stunneck D, Thamer V: Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. British Journal of Anaesthesia 1998; 81: 913-9

40. Stadnicka A, Bosnjak ZJ: Isoflurane decreases ATP sensitivity of guinea pig cardiac sarcolemmal KATP channel at reduced intracellular pH. Anesthesiology 2003; 98: 396-403

41. Stadnicka A, Kwok WM, Warltier DC, Bosnjak ZJ: Protein tyrosine kinase-dependent modulation of isoflurane effects on cardiac sarcolemmal K(ATP) channel. Anesthesiology 2002; 97: 1198-208

42. Stadnicka A, Bosnjak ZJ, Kampine JP: Modulation of cardiac inward rectifier K+ current by halothane and isoflurane. Anesth. Analg. 2000; 90: 824-33

43. Stadnicka A, Bosnjak ZJ, Kampine JP, Kwok WM: Effects of sevoflurane on inward rectifier K+ current in guinea pig ventricular cardiomyocytes. American Journal of Physiology 1997; 273: H324-32

44. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC: Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 2004; 100: 525-31

45. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC: Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels. Anesthesiology 2000; 92: 1731-9

46. Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten JR: Isoflurane-enhanced recovery of canine stunned myocardium: role for protein kinase C? Anesthesiology 1999; 91: 713-722

47. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, Tweddell JS, Fitzpatrick CM, Baker JE: Delayed cardioprotection by isoflurane: role of K(ATP) channels. American Journal of Physiology Heart & Circulatory Physiology 2002; 283

48. Turner LA, Fujimoto K, Suzuki A, Stadnicka A, Bosnjak ZJ, Kwok WM: The interaction of isoflurane and protein kinase C-activators on sarcolemmal KATP channels. Anesthesia & Analgesia 2005; 100: 1680-6

49. Marinovic J, Bosnjak ZJ, Stadnicka A: Preconditioning by isoflurane induces lasting sensitization of the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel by a protein kinase C-delta-mediated mechanism. Anesthesiology 2005; 103: 540-7

50. Tsutsumi YM, Patel HH, Lai NC, Takahashi T, Head BP, Roth DM: Isoflurane produces sustained cardiac protection after ischemia-reperfusion injury in mice. Anesthesiology 2006; 104: 495-502

51. Rainbow RD, Lodwick D, Hudman D, Davies NW, Norman RI, Standen NB: SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes. Journal of Physiology 2004; 557: 785-94

52. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E, Nakaya H: Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. Journal of Clinical Investigation 2002; 109: 509-16

53. Aizawa K, Turner LA, Weihrauch D, Bosnjak ZJ, Kwok WM: Protein kinase C-epsilon primes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to modulation by isoflurane. Anesthesiology 2004; 101: 381-9

54. Stadnicka A, Marinovic J, Bienengraeber M, Bosnjak ZJ: Impact of in vivo preconditioning by isoflurane on adenosine triphosphate-sensitive potassium channels in the rat heart: Lasting modulation of nucleotide sensitivity during early memory period. Anesthesiology 2006; 104: 503-10

55. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D’Alonzo AJ, Lodge NJ, Smith MA, Grover GJ: Cardioprotective effects of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Circ. Res. 1997; 81: 1072-1082

56. Ghosh S, Standen NB, Galinanes M: Evidence for mitochondrial KATP channels as effectors of human myocardial preconditioning. Cardiovascular Research 2000; 45: 934-940

57. Pomerantz BJ: Selective mitochandrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium. J. Thorac. Cardiovasc. Surg. 2000; 120: 387-92

58. Sato T, Sasaki N, Seharaseyon J, O’Rourke B, Marban E: Selective pharmacological agents implicate mitochondrial but not sarcolemmal KATP channels in ischemic cardioprotection. Circulation 2000; 101: 2418-23

59. Terzic A, Dzeja PP, Holmuhamedov EL: Mitochondrial KATP channels: Probing molecular identify and pharmacology. Journal of Molecular & Cellular Cardiology 2000; 32: 1911-1915

60. Jiang MT, Ljubkovic M, Nakae Y, Shi Y, Kwok WM, Stowe DF, Bosnjak ZJ: Characterization of human cardiac mitochondrial ATP-sensitive potassium channel and its regulation by phorbol ester in vitro. Am J Physiol Heart Circ Physiol 2006; 000: In press

61. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology 1997; 86: 1128-1139

62. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997; 86: 699-709

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) The Science Citation Index (SCI) is a citation index originally produced by the Institute for Scientific Information (ISI) and created by Eugene Garfield. It (Science Citation Index Expanded) covers more than 8,500 notable and significant journals, across 150 disciplines in science and technology, from 1900 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

    Top